Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 48,778,172 9.990% |
7,235,168 (+17.42%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
RA Capital Management, L.P. | 37,867 3.900% |
-20,401 (-35.01%) |
Filing History |
| 2022-01-10 5:00 pm Purchase |
2021-12-29 | 13G | Pardes Biosciences, Inc. PRDS |
RA Capital Management, L.P. | 4,431,901 7.100% |
4,431,901 (New Position) |
Filing History |
| 2021-12-22 4:32 pm Purchase |
2021-12-15 | 13G | BELLUS Health Inc. BLU |
RA Capital Management, L.P. | 10,230,274 9.900% |
10,230,274 (New Position) |
Filing History |
| 2021-12-20 4:33 pm Purchase |
2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 2,000,000 7.200% |
2,000,000 (New Position) |
Filing History |
| 2021-11-19 4:30 pm Purchase |
2021-11-19 | 13G | IO Biotech, Inc. IOBT |
RA Capital Management, L.P. | 1,857,755 6.400% |
1,857,755 (New Position) |
Filing History |
| 2021-11-15 4:35 pm Sale |
2021-11-15 | 13G | Trillium Therapeutics Inc. TRIL |
RA Capital Management, L.P. | 0 0.000% |
-5,290,481 (Position Closed) |
Filing History |
| 2021-11-15 4:35 pm Sale |
2021-11-15 | 13G | Inozyme Pharma, Inc. INZY |
RA Capital Management, L.P. | 0 0.000% |
-2,003,653 (Position Closed) |
Filing History |
| 2021-11-15 4:34 pm Purchase |
2021-11-03 | 13G | LianBio LIANY |
RA Capital Management, L.P. | 7,655,015 7.300% |
7,655,015 (New Position) |
Filing History |
| 2021-11-15 4:34 pm Sale |
2021-11-15 | 13G | Helix Acquisition Corp. HLXA |
RA Capital Management, L.P. | 0 0.000% |
-700,000 (Position Closed) |
Filing History |
| 2021-11-15 4:33 pm Sale |
2021-11-15 | 13G | Curis, Inc. CRIS |
RA Capital Management, L.P. | 0 0.000% |
-385,390 (Position Closed) |
Filing History |
| 2021-11-15 4:33 pm Sale |
2021-11-15 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 0 0.000% |
-165,749 (Position Closed) |
Filing History |
| 2021-11-15 4:32 pm Sale |
2021-11-15 | 13G | ARYA Sciences Acquisition Corp IV ARYD |
RA Capital Management, L.P. | 0 0.000% |
-1,000,000 (Position Closed) |
Filing History |
| 2021-11-15 4:31 pm Sale |
2021-11-15 | 13G | Ardelyx, Inc. ARDX |
RA Capital Management, L.P. | 0 0.000% |
-24,652,344 (Position Closed) |
Filing History |
| 2021-11-12 4:30 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 7,828,457 13.300% |
5,250 (+0.07%) |
Filing History |
| 2021-11-05 4:34 pm Purchase |
2021-10-22 | 13G | Xilio Therapeutics, Inc. XLO |
RA Capital Management, L.P. | 1,532,767 5.700% |
1,532,767 (New Position) |
Filing History |
| 2021-10-28 4:32 pm Purchase |
2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,029,184 19.050% |
17,533 (+0.19%) |
Filing History |
| 2021-10-28 4:23 pm Purchase |
2009-02-28 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 438,461 16.850% |
3,477 (+0.80%) |
Filing History |
| 2021-10-25 4:35 pm Purchase |
2021-10-13 | 13G | Otonomy, Inc. OTIC |
RA Capital Management, L.P. | 3,092,294 5.500% |
3,092,294 (New Position) |
Filing History |
| 2021-10-25 4:34 pm Purchase |
2021-10-13 | 13G | Pyxis Oncology, Inc. PYXS |
RA Capital Management, L.P. | 1,914,934 5.800% |
1,914,934 (New Position) |
Filing History |